Automate Your Wheel Strategy on ATNFW
With Tiblio's Option Bot, you can configure your own wheel strategy including ATNFW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ATNFW
- Rev/Share 0.0
- Book/Share 2.1771
- PB 0.3982
- Debt/Equity 0.0193
- CurrentRatio 1.0221
- ROIC -0.8086
- MktCap 4825280.0
- FreeCF/Share -0.3675
- PFCF -3.7093
- PE -0.4109
- Debt/Assets 0.0127
- DivYield 0
- ROE -1.4734
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About CannBioRx Life Sciences Corp. (ATNFW)
- IPO Date
- Website http://www.180lifesciences.com
- Industry Medical - Pharmaceuticals
- CEO Lloyd Blair Jordan
- Employees 4
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.